Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Oncology Stories

2014-04-09 12:31:10

VAL-083 therapy is well tolerated to date; dose limiting toxicity has not been reached after fifth cohort (20mg/m2) VANCOUVER, British Columbia and MENLO PARK, Calif., April 9, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced an update on its ongoing Phase I/II clinical trial with VAL-083 in the treatment of refractory glioblastoma multiforme (GBM). The company's new data are being presented in a poster entitled, "A Phase I/II Study of VAL-083 in...

2014-04-09 12:31:14

Three molecularly defined clusters could alter practice; 1 closely resembles deadly glioblastoma Comprehensive genomic analysis of low-grade brain tumors sorts them into three categories, one of which has the molecular hallmarks and shortened survival of glioblastoma multiforme, the most lethal of brain tumors, researchers reported at the American Association for Cancer Research Annual Meeting 2014. "The immediate clinical implication is that a group of patients with tumors previously...

2014-04-09 10:50:26

By incapacitating the activities of a protein that guides other proteins to fold into a stable shapes, Fox Chase Cancer Center researchers shut off the spigot for two proteases that help ovarian cancer cells chew their way out of the tissue they grow in and dig in at new locations. Building on earlier work that showed that inhibition of heat shock proteins—the protein origami helpers—limited metastases in ovarian cancer in mice, Shane W. O'Brien, MS, Scientific Assistant at Fox Chase...

2014-04-09 08:28:15

SANTA ROSA, Calif., April 9, 2014 /PRNewswire/ -- A new study shows that honokiol, a small molecule polyphenol extract derived from Magnolia officinalis bark, reduces proliferation of renal cell carcinoma. Conducted by researchers at the Cancer Research Laboratory at Indiana University Health, Indiana University School of Medicine, the preclinical study showed that honokiol (HonoPure®, EcoNugenics, Santa Rosa, CA) inhibited two highly aggressive renal cell carcinoma (RCC) cell lines....

2014-04-08 23:29:27

CHAMPS Oncology will be observing the 18th annual National Cancer Registrars Week (NCRW) April 7-11, 2014. Cleveland, OH (PRWEB) April 08, 2014 CHAMPS Oncology will be observing the 18th annual National Cancer Registrars Week (NCRW) April 7-11, 2014. This celebration of the cancer registry profession was founded by the National Cancer Registrars Association (NCRA). With more than 35 years in the cancer registry profession, CHAMPS Oncology is honored to join NCRA in celebrating cancer...

2014-04-08 23:27:16

Australian researchers say a serious complication associated with treating excess lung fluid in mesothelioma can be treated with radiotherapy. Raleigh, NC (PRWEB) April 08, 2014 A new study finds that mesothelioma metastasis (spreading) along the path of an indwelling pleural catheter usually responds to treatment without having to removing the catheter. Click here to read the findings, which have just been posted on the Surviving Mesothelioma website. Researchers with the Sir Charles...

2014-04-08 23:27:10

Dr. Babak Larian, Director of the CENTER for Advanced Parotid Surgery in Beverly Hills, responds to a new study that shows skin cancer survivors may have an increased risk of developing other cancers. Beverly Hills, CA (PRWEB) April 08, 2014 In response to a new study conducted by researchers at the University of Melbourne in Australia, Dr. Babak Larian of the CENTER for Advanced Parotid Surgery in Beverly Hills recently discussed how skin cancer may be linked to salivary gland cancer....

2014-04-08 12:32:28

Champions TumorGrafts(TM) Provide Accurate Predictions of Treatments' Efficacy in 81 Percent of Evaluated Patients with Advanced Sarcoma HACKENSACK, N.J., April 8, 2014 /PRNewswire/ -- Data published in Cancer show the use of personalized patient-derived xenografts, or mouse avatars, accurately predicted treatment efficacy in all evaluated patients with advanced sarcoma. The results support the predictive capabilities of Champions TumorGrafts®, developed by Champions Oncology (OTC:...

2014-04-08 12:31:36

Community Leaders throughout the North Bay Area Assemble to Join LLS in the Fight against Blood Cancers SANTA ROSA, Calif., April 8, 2014 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society's (LLS) Greater Bay Area Chapter is launching its 2014 North Bay Man & Woman of the Year (MWOY) fundraising campaign, enlisting influential and compassionate community leaders as candidates competing to raise funds for blood cancer research and cures. In its second year, the North...

2014-04-08 12:30:37

-- Peak US urology organisation CUSP Group, LLC to evaluate MiStat(TM) technology SYDNEY, April 8, 2014 /PRNewswire/ -- Private Australian biotechnology company Minomic International Ltd will launch two overseas trials of its MiStat(TM) prostate cancer screening test, following an agreement with the prestigious CUSP Group, LLC a Uro-Oncology Trials Management Organisation in the United States. An initial pilot study to be launched in April will examine 300 patient samples and is...